Business
Richard Pazdur FDA retirement: Lead drug regulator steps
Richard Pazdur FDA retirement marks the end of a significant era in oncology leadership, raising questions about future directions for the agency’s drug
Richard Pazdur FDA retirement marks the end of a significant era in oncology leadership, raising questions about future directions for the agency’s drug